JPWO2022147017A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022147017A5 JPWO2022147017A5 JP2023539811A JP2023539811A JPWO2022147017A5 JP WO2022147017 A5 JPWO2022147017 A5 JP WO2022147017A5 JP 2023539811 A JP2023539811 A JP 2023539811A JP 2023539811 A JP2023539811 A JP 2023539811A JP WO2022147017 A5 JPWO2022147017 A5 JP WO2022147017A5
- Authority
- JP
- Japan
- Prior art keywords
- pbmcs
- pharmaceutical formulation
- cryopreservation medium
- percentage
- human serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063131454P | 2020-12-29 | 2020-12-29 | |
| US63/131,454 | 2020-12-29 | ||
| PCT/US2021/065352 WO2022147017A1 (en) | 2020-12-29 | 2021-12-28 | Formulations for cryopreservation of pbmcs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024503279A JP2024503279A (ja) | 2024-01-25 |
| JP2024503279A5 JP2024503279A5 (https=) | 2024-12-25 |
| JPWO2022147017A5 true JPWO2022147017A5 (https=) | 2024-12-25 |
Family
ID=80222562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023539811A Pending JP2024503279A (ja) | 2020-12-29 | 2021-12-28 | Ｐｂｍｃの凍結保存のための製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12150982B2 (https=) |
| EP (1) | EP4271184A1 (https=) |
| JP (1) | JP2024503279A (https=) |
| CN (1) | CN116801719A (https=) |
| CA (1) | CA3203706A1 (https=) |
| TW (1) | TW202241465A (https=) |
| WO (1) | WO2022147017A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024503279A (ja) | 2020-12-29 | 2024-01-25 | スクイーズ バイオテクノロジーズ カンパニー | Ｐｂｍｃの凍結保存のための製剤 |
| CA3262748A1 (en) * | 2022-07-28 | 2024-02-01 | Stemcell Technologies Canada Inc. | IMPROVED ANTIGEN-PRESENTING CELL FORMULATIONS |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107058101B (zh) | 2011-10-17 | 2021-06-01 | 麻省理工学院 | 细胞内传递 |
| EP3033184B1 (en) | 2013-08-16 | 2021-03-31 | Massachusetts Institute of Technology | Selective delivery of material to cells |
| JP7523203B2 (ja) | 2014-10-31 | 2024-07-26 | マサチューセッツ インスティテュート オブ テクノロジー | 生体分子の免疫細胞への送達 |
| SG10201912910PA (en) | 2015-07-09 | 2020-02-27 | Massachusetts Inst Technology | Delivery of materials to anucleate cells |
| KR101851270B1 (ko) * | 2015-07-10 | 2018-04-25 | 고려대학교 산학협력단 | 자연 살해세포의 대량증식 방법 및 배양용 조성물 |
| ES2930017T3 (es) | 2015-09-04 | 2022-12-05 | Sqz Biotechnologies Co | Suministro intracelular de biomoléculas mediado por una superficie con poros |
| KR102490952B1 (ko) | 2016-05-03 | 2023-01-19 | 에스큐지 바이오테크놀로지스 컴퍼니 | 관용을 유도하는 생체분자의 세포내 전달 |
| JP7602702B2 (ja) | 2016-05-03 | 2024-12-19 | ステムセル テクノロジーズ カナダ インコーポレーテッド | 寛容性を誘導するための生体分子の細胞内送達 |
| WO2018136566A1 (en) * | 2017-01-18 | 2018-07-26 | F1 Oncology, Inc. | Methods of transducing and expanding immune cells and uses thereof |
| EP3765068A2 (en) | 2018-03-12 | 2021-01-20 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to modify immune response |
| US12599656B2 (en) | 2018-03-12 | 2026-04-14 | Stemcell Technologies Canada Inc. | Methods for treating HPV-associated diseases |
| KR20210070338A (ko) | 2018-10-04 | 2021-06-14 | 에스큐지 바이오테크놀로지스 컴퍼니 | 항원 제시 세포 기능을 증진시키기 위한 생체분자의 세포내 전달 |
| WO2020154696A1 (en) | 2019-01-25 | 2020-07-30 | Sqz Biotechnologies Company | Anucleate cell-derived vaccines |
| CA3131701A1 (en) | 2019-02-28 | 2020-09-03 | Sqz Biotechnologies Company | Delivery of biomolecules to pbmcs to modify an immune response |
| JP2024503279A (ja) | 2020-12-29 | 2024-01-25 | スクイーズ バイオテクノロジーズ カンパニー | Ｐｂｍｃの凍結保存のための製剤 |
-
2021
- 2021-12-28 JP JP2023539811A patent/JP2024503279A/ja active Pending
- 2021-12-28 WO PCT/US2021/065352 patent/WO2022147017A1/en not_active Ceased
- 2021-12-28 US US17/563,764 patent/US12150982B2/en active Active
- 2021-12-28 CA CA3203706A patent/CA3203706A1/en active Pending
- 2021-12-28 EP EP21854847.7A patent/EP4271184A1/en active Pending
- 2021-12-28 CN CN202180093178.3A patent/CN116801719A/zh active Pending
- 2021-12-28 TW TW110149072A patent/TW202241465A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fogh et al. | Continuous cultivation of epithelial cell strain (FL) from human amniotic membrane. | |
| JP5777956B2 (ja) | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 | |
| JP2021517895A5 (https=) | ||
| JP2021517813A5 (https=) | ||
| KR20210121106A (ko) | 무핵 세포-유래된 백신 | |
| RU2612154C2 (ru) | Способ культивирования адгезионных клеток | |
| EP0028563A1 (en) | Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer | |
| CN114946830B (zh) | 一种基于响应面优化的细胞外囊泡的储存液及其制备方法 | |
| CA2687534A1 (en) | Method for production of dendritic cell | |
| US20260078340A1 (en) | Scaffolds with stabilized mhc molecules for immune-cell manipulation | |
| JPWO2019178005A5 (https=) | ||
| De Mars et al. | A method of selecting for auxotrophic mutants of HeLa cells | |
| JPWO2022147017A5 (https=) | ||
| JPH10505827A (ja) | Ｄ▲下２▼ｏ含有医薬組成物 | |
| Huang et al. | Maturation of dendritic cells for enhanced activation of anti-HIV-1 CD8+ T cell immunity | |
| WO2021038089A1 (en) | Minimal messenger rnas and uses thereof | |
| US12150982B2 (en) | Formulations of PBMCs | |
| Shankar et al. | Interferon-γ added during Bacillus Calmette-Guerin induced dendritic cell maturation stimulates potent Th1 immune responses | |
| Yoshimura et al. | In vitro differentiation of chicken embryo skin cells transformed by Rous sarcoma virus | |
| US20250339530A1 (en) | Enhanced antigen presenting cell formulations | |
| Wang et al. | Modulation of immune system function by measles virus infection. II. Infection of B cells leads to the production of a soluble factor that arrests uninfected B cells in G0/G1 | |
| US20250339526A1 (en) | Methods for treating cancer with enhanced antigen presenting cells | |
| Hu | Targeting antigens to phosphatidylserine triggers rapid T-and B-cell responses | |
| WO2012160702A1 (ja) | 樹状細胞の分化・培養方法 | |
| Yoshida et al. | Assessment of monocyte derived dendritic cell phenotype upon biomaterial contact in vitro |